A new paper from the University of Kansas overturns the idea that a "risk gene" carried by millions of people worldwide influences production of Type 1 interferon, a workhorse of the immune system.
Photo taken on a light microscope of bone marrow derived dendritic cells generated for the study at the University of Kansas. LAWRENCE — A new paper from the University of Kansas overturns the idea ...
Despite potential benefits, the therapy remains in limited use for myeloproliferative neoplasms (MPNs). Pegylated interferons are a meaningful therapeutic option for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results